Psych Vivas · Child and adolescent psychiatry — adolescent substance use
Adolescent substance use — structured clinical viva
Fellowship viva on adolescent substance use across cannabis/alcohol/stimulants, family interventions, dual diagnosis, harm reduction, and CAMHS–AOD disposition.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
This is a polysubstance adolescent presentation with dual mental health risk (low mood, NSSI) and parental demand for coercive residential care. Minimise neither cannabis potency/frequency nor family distress.[5][6]
Assessment framework. Confidentiality-with-safety; private interview; CRAFFT then full pattern (high-THC daily, alcohol binges, methamphetamine); dual screen (mood, self-harm, psychosis, ADHD, trauma); family monitoring capacity; school interface; toxicology as adjunct not alliance test.[1]
Evidence-based care. MI for ambivalence; family-based therapy as core psychosocial (Waldron); name MDFT (Rigter) and CYT packages; brief alcohol intervention evidence; harm reduction goals (driving, binge reduction, school) per Stockings; concurrent dual care not sequential exclusion.[2][3][4][6][7]
Family communication. Validate fear; reject pejorative "boot camp only" as first step when outpatient family work is appropriate and home is safe; escalate intensity if risk high.[7]
Pharmacotherapy context. Limited for cannabis/stimulants; if opioid OUD were present, cite Woody extended BUP/NX vs short detox — not the main pathway here.[8]
Difference from adult topics. Developmental brain context, family therapy primacy, school/Gillick/confidentiality, CAMHS–AOD interface, and youth trial evidence (CYT/MDFT/CRAFFT) rather than adult AUD pharmacotherapy algorithms.[1][2][6]
References8ShowHide
- [1]Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients Arch Pediatr Adolesc Med, 2002.PMID 12038895
- [2]Waldron HB, Turner CW Evidence-based psychosocial treatments for adolescent substance abuse J Clin Child Adolesc Psychol, 2008.PMID 18444060
- [3]Rigter H, Henderson CE, Pelc I, et al. Multidimensional family therapy lowers the rate of cannabis dependence in adolescents: a randomised controlled trial in Western European outpatient settings Drug Alcohol Depend, 2013.PMID 23140805
- [4]Dennis M, Godley SH, Diamond G, et al. The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials J Subst Abuse Treat, 2004.PMID 15501373
- [5]Silins E, Horwood LJ, Patton GC, et al. Young adult sequelae of adolescent cannabis use: an integrative analysis Lancet Psychiatry, 2014.PMID 26360862
- [6]Stockings E, Hall WD, Lynskey M, et al. Prevention, early intervention, harm reduction, and treatment of substance use in young people Lancet Psychiatry, 2016.PMID 26905481
- [7]Drake RE, Mercer-McFadden C, Mueser KT, et al. Review of integrated mental health and substance abuse treatment for patients with dual disorders Schizophr Bull, 1998.PMID 9853791
- [8]Woody GE, Poole SA, Subramaniam G, et al. Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial JAMA, 2008.PMID 18984887